Name | CAS NO. | Usage |
AICAR | 2627-69-2 |
acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 |
medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 |
for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 |
under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 | 431579-34-9 |
YK11: a SARM and myostatin inhibitor in one |
AC262356 | 870888-46-3 | New SARMS |
SR9011 | 1379686-29-9 | New SARMS |
S23 | 1010396-29-8 | New SARMS |
GW0724 | 317318-84-6 | New SARMS |
Peptides | |||
AOD-9604 | 2mg*10vials*1kit | Ipamorelin | 2mg*10vials*1kit |
CJC-1295 | 2mg*10vials*1kit | Melanotan | 10mg*10vials*1kit |
CJC-1295 DAC | 2mg*10vials*1kit | Melantotan II | 10mg*10vials*1kit |
DSIP | 5mg*10vials*1kit | MGF | 2mg*10vials*1kit |
Folli-315 | 1mg*10vials*1kit | Myostatin HMP | 1mg*10vials*1kit |
Folli-344 | 1mg*10vials*1kit | PEG MGF | 2mg*10vials*1kit |
GHRP-2 | 5mg*10vials*1kit | PT-141 | 10mg*10vials*1kit |
GHRP-6 | 5mg*10vials*1kit | Selank | 2mg*10vials*1kit |
Hexarelin | 2mg*10vials*1kit | TB-500 | 2mg*10vials*1kit |